IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Coronary Obstruction Detection by Molecular Personalized Gene Expression (COMPASS)
This study has been completed.
Sponsor:
CardioDx
Collaborators:
Cardiovascular Research Foundation, New York
Piedmont Heart Institute, Inc., Atlanta, GA
Information provided by (Responsible Party):
CardioDx
ClinicalTrials.gov Identifier:
NCT01117506
First received: May 3, 2010
Last updated: November 25, 2014
Last verified: November 2014
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2012 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):